Latest news
Seres Therapeutics Inc (MCRB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 15:13:05 GMTSeres Therapeutics exits more Cambridge real estate early - The Business JournalsThe Business Journals · Wed, 05 Aug 2026 21:16:00 GMTSeres Therapeutics Q2 Operating Income USD -2 - MoomooMoomoo · Wed, 05 Aug 2026 15:28:36 GMTSeres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - tradingview.comtradingview.com · Wed, 05 Aug 2026 13:13:24 GMTSeres Therapeutics (MCRB) Q2 Revenue Surpasses Expectations Amid Clinical Progress - GuruFocusGuruFocus · Wed, 05 Aug 2026 13:03:49 GMTSeres Therapeutics Q2 Net Income Reaches $4.6 Million - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:16:00 GMTMCRB: Returned to profitability in Q2 2026, driven by VOWST sale gains and SER-155 trial success - tradingview.comtradingview.com · Wed, 05 Aug 2026 11:12:40 GMTSeres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs - ca.finance.yahoo.comca.finance.yahoo.com · Wed, 05 Aug 2026 11:00:00 GMT